Fig. 2From: Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort studyScreening process to identify TNFi insensitive patients. TNFi, tumour necrosis factor inhibitor; bDAMRD, biologic disease-modifying anti-rheumatic drug; DAS, disease activity score, CRP, c-reactive proteinBack to article page